Janux is a clinical-stage company developing unique immunotherapies that have the potential to generate tumor-specific immune responses to attack and kill tumors without destroying a patient’s healthy tissue. Janux is using its platform masking technology to engineer novel drug candidates that are designed to overcome the traditional T cell engager toxicity and efficacy limitations. Janux is proud to have earned a 𝐆𝐫𝐞𝐚𝐭 𝐏𝐥𝐚𝐜𝐞 𝐓𝐨 𝐖𝐨𝐫𝐤 𝐂𝐞𝐫𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧™ in 2024.
Company Details
- Employees
- 101
- Founded
- -
- Address
- 10955 Vista Sorrento Pkwy,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.januxrx.com/
- Keywords
- Biotechnology.
- HQ
- San Diego, California
Janux Therapeutics Questions
Janux Therapeutics's website is https://www.januxrx.com/
Janux Therapeutics's LinkedIn profile is https://www.linkedin.com/company/janux-therapeutics
Janux Therapeutics has
101 employees.
View email and phone details for 101
employees at Janux Therapeutics.
Janux Therapeutics's industry is
Biotechnology Research
Janux Therapeutics's top competitors are
Neurocrine Biosciences,
Acadia Pharmaceuticals Inc.,
Viking Therapeutics, Inc.,
Ionis Pharmaceuticals, Inc.,
Denali Therapeutics,
Avidity Biosciences, Inc.,
Adarx Pharmaceuticals Inc.,
Ventyx Biosciences,
Crinetics Pharmaceuticals,
Poseida Therapeutics, Inc..
Janux Therapeutics's categories are Biotechnology Research
Janux Therapeutics's founding year is 2017
